Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.

The USPTO has granted a patent to Vistagen’s non-opioid oral product candidate AV-101 for neuropathic pain treatment.

ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.

Nandita Vijayasimha, Bengaluru Thursday, February 6, 2025, 08:00 Hrs [IST] ...

Revenues increased 14% for the quarter compared to prior year and 13% year-to-datePositive cash flow from operations for the quarter with $5.2 million of cash at December 31, 2024Year-to-date net loss ...

If your ability to connect with others feels a little rusty post-pandemic, adding “social fitness” to your workout routine ...

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

The new trial will evaluate the safety and efficacy of the vaccine administered via two routes: inhaled into the lungs and sprayed into the nose. “I am delighted to see this nasal vaccination ...

Ms. Fogarty has served at Tonix since 2016, most recently as Executive Vice President, Product DevelopmentTonix is Preparing for Potential Launch ...

Developed in Burma in the late 19th century and eventually marketed to mass appeal, Tiger Balm is an impressive temporary ...

Mumbai: Global pharma major Lupin Limited has announced that it has received tentative approval from the United States Food ...